文献速递MDS 与骨髓增殖性肿瘤

单细胞转录组揭示原发性血小板增多症分子异质性

Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia.
PubMed 文献 · Br J Haematol · 2019-10-14

该研究对7例初治ET患者和1名健康成人的外周血CD34+细胞进行单细胞RNA测序,患者突变谱为JAK2 V617F 2例、CALR 3例、三阴性2例。结果显示JAK/STAT信号激活在不同样本中见于不同祖细胞谱系,ET患者与对照、不同驱动突变患者乃至相同驱动突变患者之间均存在显著分子差异,并发现个体内克隆多样性。

要点

  • ET患者CD34+细胞存在显著个体间分子异质性
  • JAK/STAT信号激活的祖细胞谱系在不同样本间不一致
  • 同一驱动突变患者间仍存在分子差异及个体内克隆多样性

核心结论

  • 单细胞RNA测序拓展了对ET克隆多样性和个体间异质性的认识。

研究设计与样本

  • 研究对7例初治ET患者和1名健康成人的外周血CD34+细胞进行单细胞RNA测序。
  • 患者突变谱为JAK2 V617F 2例、CALR 3例(1例I型、2例II型)、三阴性2例。

主要发现

  • 不同样本中JAK/STAT信号激活见于不同的祖细胞谱系。
  • ET患者与对照、不同驱动突变患者之间以及相同驱动突变患者之间均存在显著分子差异。
  • 在一例患者的CD34+祖细胞群中发现个体内克隆多样性,可能提示多克隆存在。
  • 基于细胞免疫表型估计亚群大小提示所有分析样本均存在分化偏倚。
  • 结合转录组信息与靶向测序数据可识别分子相关的关键体细胞突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Significant phenotypic heterogeneity exists in patients with all subtypes of myeloproliferative neoplasms (MPN), including essential thrombocythaemia (ET). Single-cell RNA sequencing (scRNA-Seq) holds the promise of unravelling the biology of MPN at an unprecedented level of resolution. Herein we employed this approach to dissect the transcriptomes in the CD34+ cells from the peripheral blood of seven previously untreated ET patients and one healthy adult. The mutational profiles in these patients were as follows: JAK2 V617F in two, CALR in three (one type I and two type II) and triple-negative (TN) in two. Our results reveal substantial heterogeneity within this enrolled cohort of patients. Activation of JAK/STAT signalling was recognized in discrepant progenitor lineages among different samples. Significantly disparate molecular profiling was identified in the comparison between ET patients and the control, between patients with different driver mutations (JAK2 V617F and CALR exon 9 indel), and even between patients harbouring the same driver. Intra-individual clonal diversity was also found in the CD34+ progenitor population of a patient, possibly indicating the presence of multiple clones in this case. Estimation of subpopulation size based on cellular immunophenotyping suggested differentiation bias in all analysed samples. Furthermore, combining the transcriptomic information with data from targeted sequencing enabled us to unravel key somatic mutations that are molecularly relevant. To conclude, we demonstrated that scRNA-Seq extended our knowledge of clonal diversity and inter-individual heterogeneity in patients with ET. The obtained information could potentially leapfrog our efforts in the elucidation of the pathogenesis of the disease.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Hsu CC, Chen YJ, Huang CE, et al. Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia. Br J Haematol. 2019. PMID: 31610612. doi:10.1111/bjh.16225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。